Murali Ramachandran bought KAPA
October 8, 2025 · Form 4 insider transaction
Murali Ramachandran bought 152,672 shares of Kairos Pharma, Ltd. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 49 days after the transaction.
Direction
Acquired (buy-side)
Shares
152,672
Price
$0.00
Total value
N/A
InsiderMurali Ramachandran
Role—
CompanyKairos Pharma, Ltd. (KAPA)
SecurityCOMMON STOCK
Transaction codeA: Grant or award
Transaction dateOctober 8, 2025
Filing dateNovember 26, 2025
Shares owned after299,529
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents 152,672 restricted stock units ("RSUs") issued to the Reporting Person under the Kairos Pharma, Ltd. 2023 Equity Incentive Plan. The 152,672 RSUs are scheduled to vest in full on the first anniversary of the grant date.; Consists of (1) 142,191 shares of common stock and (2) 157,338 RSUs which remain subject to vesting.